Author:
Djordjevic Natasa,Carrillo Juan Antonio,Gervasini Guillermo,Jankovic Slobodan,Aklillu Eleni
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference44 articles.
1. Oscarson M (2001) Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. Drug Metab Dispos 29:91–95
2. Oscarson M, McLellan RA, Gullsten H et al (1999) Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett 448:105–110
3. Kimura M, Yamazaki H, Fujieda M et al (2005) CYP2A6 is a principal enzyme involved in hydroxylation of 1, 7-dimethylxanthine, a main caffeine metabolite, in humans. Drug Metab Dispos 33:1361–1366
4. Nowell S, Sweeney C, Hammons G et al (2002) CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 11:377–383
5. Hukkanen J, Jacob P III, Benowitz NL (2005) Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79–115
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献